Few Steps from Creation to the Consumption

With GST, however, simplicity is suddenly able to yield rich dividends for drug manufacturers. And they’re getting rid of dead weight. Upendra Dinani, chairman and managing director of Nasik-based D. Vijay Pharma, a distributor, and C&F for multiple pharma companies, knew times were going to be tough post-GST. In April 2017, Emcure Pharmaceuticals went from … Read moreFew Steps from Creation to the Consumption

It was reported that thrombosis occurred in the Absorb

“I think Absorb has dampened the enthusiasm for companies,” Sripal Bangalore, a cardiologist at New York University who has done clinical trials for Abbott, said. “It’s still a lot of investment to kind of fine-tune this technology. But I’m hoping that other companies with thinner scaffolds will have favorable results.” Abbott, too, is working on … Read moreIt was reported that thrombosis occurred in the Absorb

C-sections and the conundrum of giving birth in India

Seher could not have been happier when she found out that she was pregnant in February 2017. As is often the case with overwhelming news, her delight soon turned to confusion. Is maternity leave enough? Where would she find a nanny she could trust? Breast milk or not? Her mother, mother-in-law, and aunts, however, had … Read moreC-sections and the conundrum of giving birth in India

The government sees serious adverse events

What, then, do we make of the lack of awareness in India of the rotavirus vaccine’s risk of intussusception? Or of nearly 1% of PCV users reporting adverse events like bronchiolitis (an infection of the lungs), gastroenteritis (inflammation of the stomach and small intestine) and pneumonia? Underpinning all this is NTAGI’s non-disclosure clause, where members … Read moreThe government sees serious adverse events

A Speck in the Multi-Billion Dollar Universe

Back in the 1980s, MNCs dominated the Indian pharmaceutical market. They controlled an 80% stake, while domestic companies accounted for the rest. This has reversed starting in the early 2000s, with Indian companies accounting for 79% of the Rs 1,21,833 crore ($16.80 billion)-market, as of FY18. The demoralizing decrease at every stage The market grew … Read moreA Speck in the Multi-Billion Dollar Universe

The value of a cancer patient’s life

The president of the Indian Society Of Oncology, Dr. Dinesh Pendharkar, agreed with Menghaney. In cancer treatment, every oncologist needs to follow clinical practice guidelines, said Pendharkar. The most widely followed guidelines globally and in India are written by the national comprehensive cancer network (NCCN) – a US-based not-for-profit alliance of 28 leading cancer centers. … Read moreThe value of a cancer patient’s life

Diabetes a lifelong disorder, and overcoming the same

It is reliably learned that Biocon bypassed Wellthy, which is found to be a rather inferior copy of Welldoc, a US FDA-approved digital therapy company. Moreover, Wellthy is into lifestyle management. Geographical Diversity in India Whereas the digital tool that Biocon plans to launch will take into consideration geographic diversity in India and focus on … Read moreDiabetes a lifelong disorder, and overcoming the same